You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0157 Clinical Outcomes at Week 104 and Analysis of Associated Baseline Factors after An Initial 1 Year of Certolizumab Pegol and MTX Treatment in MTX-Naïve Patients with Early RA: Results from The Second Year of The C-Opera Study

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
THU0157 Clinical Outcomes at Week 104 and Analysis of Associated Baseline Factors after An Initial 1 Year of Certolizumab Pegol and MTX Treatment in MTX-Naïve Patients with Early RA: Results from The Second Year of The C-Opera Study

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 20161802
Aug 20161003
Sep 20161502
Oct 20161701
Nov 20161000
Dec 2016900
Jan 2017802
Feb 20171501
Mar 2017300
Apr 2017900
May 20171504
Jun 20171302
Jul 20173600
Aug 20173800
Sep 20171600
Oct 20171801
Nov 2017400
Dec 20171200
Jan 20181200
Feb 20181000
Mar 2018400
Apr 2018600
May 20183001
Jun 2018600
Jul 20182200
Aug 2018400
Sep 2018400
Oct 2018400
Nov 2018600
Dec 20181200
Jan 2019200
Feb 2019200
Mar 2019200
Apr 2019401
May 2019200
Jul 2019200
Oct 20191200
Nov 2019200
Dec 2019600
Mar 2020201
Jun 20201000
Jul 20201400
Aug 2020800
Sep 20201600
Nov 2020200
Dec 2020600
Jan 2021600
Feb 2021804
Mar 2021400
Apr 2021200
Oct 2021200
Nov 2021600
Dec 20212001
Jan 20221501
Feb 2022600
Mar 20222200
Apr 2022400
May 20222100
Jun 20221001
Jul 2022600
Aug 20221400
Sep 20222402
Oct 2022400
Nov 2022600
Dec 20221400
Jan 20231600
Feb 20231601
Mar 2023400
Apr 2023500
May 2023400
Jul 2023800
Aug 2023200
Sep 2023800
Dec 20232101
Jan 2024200
Feb 2024200
Mar 2024200
Total762032